Breaking News
Josh Russell, AST, on Small Patch Applications for Drug Products
In this interview, Josh Russell from AST discusses the range of products offered by the company that are designed for small-batch applications that require precision handling and accurate dosing. The company offers four different products, each with unique features tailored to meet specific customer requirements.
According to Russell, customers in this field often face challenges related to the high value of their products and the need for highly accurate dosing and handling. However, AST provides solutions to these challenges through its product line.
One of the key advantages of AST’s systems is their flexibility to adapt to emerging needs in a customer’s product pipeline. The systems are also designed for simplicity, making them easy to upgrade or update.
Finally, Russell notes that AST’s systems are known for their flexibility and efficient delivery, as they are designed with a modular system that allows for quick validation and quicker delivery compared to other systems on the market. Overall, this interview provides insight into the products and solutions offered by AST for small-batch applications that require precision handling and accurate dosing.
People In This Post
Companies In This Post
- Insmed Completes Enrollment of Adult Patients in Phase 3 ASPEN Study of Brensocatib in Bronchiectasis Read more
- NEC Establishes Subsidiaries in Europe for Strengthening Global AI Drug Development Business Read more
- Flare Therapeutics Further Strengthens Leadership Team with Key Executive Appointments and Promotions Read more
- Sensorion Appoints Khalil Barrage as Interim Chairman of the Board Read more
- Ablaze Pharmaceuticals Plans Development of Innovative GPC3 Targeted Radiopharmaceutical Therapy for Liver Cancer in Greater China Read more
Katsuyuki Takeuchi, Terumo, on Medical Care Solutions
In this video, Katsuyuki Takeuchi, the Global Product Manager at Terumo Pharmaceutical Solutions, discusses the […]
Lena Wagner & Simone Marquardt, Raumedic, on Components for the Pharmaceutical and MedTech Industries
In this video, Lena Wagner and Simone Marquardt from Raumedic discuss the components that the […]
Sian Eden & Olivia Houselander, Owen Mumford, on Medical Devices
In this video, Sian Eden and Olivia Houselander from Owen Mumford, a medical device company, […]
Catherine Bianchi, Saint-Gobain, on Pharmaceutical Products
In the video, Catherine Bianchi, Marketing Group Leader of Bioprocess Solutions at Saint-Gobain, introduces the […]
Chris Philpott, Boddingtons, on Injection Molding
In this video, Chris Philpot, the Commercial and Technical Manager at Boddingtons, highlights the capabilities […]
Mario Franco Ruiz, H&T Presspart, on Innovation for Medical Devices
In the video, Mario Franco Ruiz, Sales Manager at H&T Presspart, discusses the company’s latest […]
Jared O’Connell, Honeywell, on Sustainability and Innovation
In this video, Jared O’Connell, the General Manager of Healthcare Packaging at Honeywell, discusses what […]
Insmed Completes Enrollment of Adult Patients in Phase 3 ASPEN Study of Brensocatib in Bronchiectasis
Insmed Incorporated, a global biopharmaceutical company on a mission to transform the lives of patients […]
NEC Establishes Subsidiaries in Europe for Strengthening Global AI Drug Development Business
NEC Corporation and NOI announced that NOI will be realigned as a subsidiary of NEC […]
Flare Therapeutics Further Strengthens Leadership Team with Key Executive Appointments and Promotions
Flare Therapeutics, a biotechnology company targeting transcription factors to discover precision medicines for cancer and […]
Sensorion Appoints Khalil Barrage as Interim Chairman of the Board
Sensorion, a pioneering clinical-stage biotechnology company that specializes in gene therapies in the ear, announces […]
Ablaze Pharmaceuticals Plans Development of Innovative GPC3 Targeted Radiopharmaceutical Therapy for Liver Cancer in Greater China
Ablaze Pharmaceuticals, a biotech company that is focused on developing Targeted Radiotherapy (TRT) to benefit […]
Hansa Biopharma Completes Enrollment in Phase 2 Study of Imlifidase in Guillain-Barré Syndrome (GBS)
Hansa Biopharma, a pioneer in enzyme technology for rare immunological conditions, today announced it has […]
ProJenX Announces Formation of Scientific Advisory Board for Development of ALS Treatment
ProJenX, a clinical-stage biotechnology company developing novel, brain-penetrant therapies targeting biologically-defined pathways for the treatment […]